AWW admin

An audit of Australia's paediatric gender guideline raises serious questions about evidence, informed consent and diagnostic safeguards. When we treat children in medicine, we apply more care, not less. The younger and more vulnerable the patient, the higher the duty to get the basics right: current evidence, full disclosure of risks, and clear processes for who decides what. This is not contentious. It is how Australian medicine is meant to work, and it is what parents, regulators and the...

1. NZ Has Halted Puberty Blockers for New Cases Key Message: The Government has placed a moratorium on prescribing puberty blockers (GnRH analogues) to new patients presenting with gender dysphoria or incongruence. Quote from Beehive: “New patients… can no longer be prescribed gonadotropin-releasing hormone analogues.” Clinical implication: Doctors should not initiate puberty blockers for gender dysphoria outside a formal clinical trial. No such trial currently exists in NZ. 2. Government...

🇳🇿 The New Zealand Government has just announced a full halt on prescribing puberty blockers (GnRH analogues) to any new patients for gender dysphoria or gender incongruence. This brings NZ into alignment with the UK , following the Cass Review. 🔒 What the Cabinet Decision Means According to the Beehive statement: 1. New youth patients can NO LONGER be prescribed puberty blockers for gender dysphoria. “New patients seeking treatment for gender dysphoria or incongruence can no longer be...